This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
The Optima Group is building another CSPE Center at its headquarters in Schwaebisch Hall, to be used for the assembly and comprehensive commissioning of pharmaceutical filling lines. This will expand the production area by around 46,000 square feet (4,300 square meters) and also provide new office space. At Optima Pharma's site in Gladenbach-Mornshausen (Hesse, Germany), the existing assembly hall for freeze-drying systems is being expanded by 50%. The investment is due to the high volume of orders received and ongoing developments in the Optima Group’s Pharma Division.
The Optima Group is experiencing high demand for filling and packaging solutions. This is particularly true of the Pharma Division. There was a short-term increase in the already high order backlog caused by the COVID-19 pandemic. In light of this, production capacities are being expanded at the Schwaebisch Hall and Gladenbach-Mornshausen (Marburg-Biedenkopf County, Hesse) sites.
Fast process flows and short time-to-market
Optima Pharma opened its first CSPE (Comprehensive Scientific Process Engineering) Center at its headquarters in Schwaebisch Hall, Germany, in June, 2019. Ever since, the CSPE Center has been fully utilized, so the new building has been designed to be 25% larger, with an almost identical design. Completion is planned for late 2021. CSPE expedites processes from system design to production start. One part of this is integrated (complete) Factory Acceptance Tests of entire lines (iFATs). The new building covers a total area of around 75,000 square feet (7,000 square meters) and has state-of-the-art equipment, enabling joint Factory Acceptance Tests to be carried out on the filling and closing systems and isolators under realistic production conditions. In the approximately 46,000-square-foot (4,300-square-meter) assembly area, the emerging pharmaceutical lines will be supplied with process heating and cooling as well as demineralized water and compressed air via supply lines during commissioning, cycle development and iFAT. CSPE Center testing ensures that both the subsequent installation and the Site Acceptance Test (SAT) at the customer's site proceed much faster. For Optima's customers, this shortens the time from product development to market launch by several months. The building will be equipped with a separate logistics area. The employees will also enjoy optimal working conditions in the spaciously designed three-floor office building.
The CSPE approach takes effect: CSPE 2.0 is in the wings
The successful concept will therefore be expanded further. "Integration levels are set to become even greater in future, as part of CSPE 2.0. Work that in the past typically took place on the customer's site will have already been carried out to an even greater extent in one of our CSPE Centers," says Gerhard Breu, Chairman of the Optima Pharma Division. Another customer request concerns GMP-compliant cycle development, which can be handled entirely by Optima Pharma in the future. "This again significantly increases the level of integration, which, in turn, shortens the commissioning phase at the customer's site even further," Breu explains.
Hall extension in Gladenbach-Mornshausen completed in record time
An expansion of capacity was also needed at the Optima Pharma site in Gladenbach-Mornshausen. The freeze-drying systems manufactured there are used in many turnkey projects, together with filling and closing lines from Schwaebisch Hall or as a stand-alone solution. The existing multi-story assembly hall with approximately 27,000 square feet (2,500 square meters) of assembly space is being expanded by around 11,000 square feet (1,000 square meters). "This investment will enable us to further increase our production and thus create the best conditions for further growth at the Gladenbach-Mornshausen site," explains Stephan Reuter, the Managing Director. The groundbreaking ceremony took place in October 2020.
